Mirivadelgat

N/A

Report date: 2024/12/13 16:15:50
NME

Base Information

Drug NameMirivadelgat
Drug Alias NameFP-045FRS-045
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldehyde dehydrogenase stimulants
TargetsAldehyde dehydrogenase
Therapy Area/IndicationsFanconi AnemiaPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesForesee Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsFanconi Anemia

Other Information

ATC CodeN/A
Related LinksN/A